Atlas FDA

Optune Lua

FDA premarket approval P230042/S002 · decided 2025-06-04

Approval details

PMA number
P230042
Supplement
S002
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Optune Lua
Generic name
Electrical tumor treatment fields for non-small cell lung cancer
Applicant
Novocure, GmbH
Date received
2025-05-21
Decision date
2025-06-04
Days to decision
14 days
Decision code
OK30
Product code
SDA
Advisory committee
Anesthesiology
Expedited review
No
Location
Baar
Statement
addition of a second supplier for the thermistor component of the ITE Transducer Arrays

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.